A pregnant patient at 28 weeks has a fundal height measuring 34 cm. Before you assume twins, you need to know what's normal at each visit — and what triggers further workup.
Routine prenatal assessment follows a predictable visit schedule: every 4 weeks through 28 weeks, every 2 weeks from 28–36 weeks, then weekly until delivery. Each visit includes weight, blood pressure, urine dipstick (protein and glucose), fundal height, fetal heart tones (FHTs), and fetal presentation (from about 32 weeks via Leopold maneuvers). Fundal height in centimeters should approximate gestational age in weeks (±2 cm) between 20 and 36 weeks — a discrepancy of more than 2 cm warrants ultrasound to evaluate for growth restriction, macrosomia, polyhydramnios, or dating error. FHTs are auscultated with a Doppler starting at 10–12 weeks; normal range is 110–160 bpm. Quickening (maternal perception of fetal movement) typically occurs at 16–20 weeks for primigravidas, 14–16 weeks for multigravidas. Edema of the hands and face is abnormal and warrants blood pressure and proteinuria evaluation, while dependent ankle edema alone is a common physiologic finding. Each visit is an opportunity to assess for warning signs: vaginal bleeding, persistent headache, visual changes, epigastric pain, decreased fetal movement, and signs of preterm labor.
Key Distinctions
Don't confuse fundal height discrepancy (>2 cm off from gestational age) with normal variation — it always requires follow-up imaging. Students mix up when FHTs are first heard by Doppler (10–12 weeks) versus fetoscope (18–20 weeks). Ankle edema is physiologic; hand or facial edema is a red flag requiring preeclampsia workup — don't normalize all swelling in pregnancy.
Clinical Pearl
Fundal height = gestational age ± 2 cm. Think of it as a built-in ruler — when the ruler is off, the picture (ultrasound) comes next.
Prenatal Nutrition & Patient Education
Prenatal nutrition centers on quality over quantity. Caloric needs increase by only about 340 kcal/day in the second trimester and 450 kcal/day in the third — not "eating for two." Total recommended weight gain depends on pre-pregnancy BMI: 25–35 lbs for normal weight, 15–25 lbs for overweight, 11–20 lbs for obese, and 28–40 lbs for underweight patients. Folic acid (400–800 mcg daily) is the single most critical supplement, ideally started one month before conception and continued through the first trimester to prevent neural tube defects. Iron needs rise to 27 mg/day to support expanded blood volume, and iron is best absorbed with vitamin C, not with calcium or antacids. Calcium stays at 1,000 mg/day but must come from diet or supplements since the fetus will leech maternal stores. Vitamin A in excess (>10,000 IU/day) is teratogenic — patients should avoid retinol-based supplements and limit liver intake. Prenatal education also includes food safety: avoid raw fish, unpasteurized dairy, deli meats (listeriosis risk), and high-mercury fish (shark, swordfish, king mackerel, tilefish). Caffeine should stay under 200 mg/day.
Key Distinctions
Don't confuse folic acid's role (neural tube closure in first 28 days) with iron's role (supporting maternal blood volume expansion) — students mix up timing and purpose. Vitamin A excess is teratogenic, but beta-carotene from plants is not — only preformed retinol is dangerous. Weight gain recommendations vary by BMI category; a single number answer is always wrong.
Clinical Pearl
Folic acid before the positive test — by the time the patient knows about the pregnancy, the neural tube is already closing. That's why preconception counseling matters.
Prenatal Screening Tests
Prenatal screening tests estimate the probability of chromosomal abnormalities and neural tube defects without confirming them. First-trimester screening (weeks 10–13) combines nuchal translucency ultrasound with maternal serum markers (free β-hCG and PAPP-A). Increased nuchal translucency with high β-hCG and low PAPP-A raises suspicion for trisomy 21. The quad screen (weeks 15–20) measures AFP, hCG, estriol, and inhibin A. Elevated AFP suggests an open neural tube defect; low AFP with high hCG and inhibin A suggests Down syndrome. Cell-free fetal DNA (cfDNA) testing can be drawn as early as 10 weeks and screens for trisomies 13, 18, and 21 with high sensitivity, but it remains a screening test — not diagnostic. An abnormal screen means the patient needs counseling and a referral for diagnostic testing such as amniocentesis or CVS. The nurse's role centers on ensuring the patient understands that a positive screen does not equal a diagnosis, managing anxiety, confirming accurate gestational dating (which directly affects AFP interpretation), and supporting informed decision-making without directing the outcome.
Key Distinctions
Don't confuse screening (risk probability) with diagnostic tests like amniocentesis (definitive karyotype) — this atom covers screens only. Students mix up high AFP (neural tube defect) with low AFP (Down syndrome); the direction of AFP is the pivot point. cfDNA is highly accurate but is still classified as screening, not diagnosis.
Clinical Pearl
AFP goes UP for open defects (think: open tube leaks protein out) and DOWN for Down syndrome. Direction of AFP tells you the worry.
Invasive Prenatal Diagnostics
Invasive prenatal diagnostics — amniocentesis and chorionic villus sampling (CVS) — provide definitive genetic and chromosomal diagnoses, unlike screening tests that only estimate risk. CVS is performed at 10–13 weeks by aspirating placental chorionic villi; it gives early results but cannot detect neural tube defects. Amniocentesis is typically done at 15–20 weeks by inserting a needle through the abdominal wall into the amniotic sac under ultrasound guidance; it detects chromosomal abnormalities, neural tube defects (via alpha-fetoprotein in the fluid), and fetal lung maturity in late pregnancy (lecithin-to-sphingomyelin ratio ≥ 2:1 indicates maturity). Before either procedure, the nurse verifies informed consent, obtains a baseline fetal heart rate, confirms Rh status (Rh-negative mothers receive RhoGAM after the procedure to prevent isoimmunization), and ensures the patient has a full bladder for CVS or an empty bladder for amniocentesis. Post-procedure monitoring includes assessing for vaginal bleeding, fluid leakage, cramping, fever, and decreased fetal movement. The patient is instructed to rest and avoid strenuous activity for 24 hours. Both procedures carry a small risk of miscarriage — approximately 0.1–0.3% for amniocentesis and slightly higher for CVS.
Key Distinctions
Don't confuse CVS with amniocentesis timing: CVS is first trimester (10–13 weeks), amniocentesis is second trimester (15–20 weeks). Students mix up bladder prep — full bladder for CVS (tilts uterus for access), empty bladder for amniocentesis (prevents puncture). Screening tests estimate probability; invasive diagnostics give a definitive yes-or-no chromosomal diagnosis. A positive screening doesn't equal a diagnosis.
Clinical Pearl
Full for CVS, empty for amnio — match the bladder to the procedure. And always check Rh status: if negative, RhoGAM goes in before the patient leaves.